Home/BioVie/David Morse
DM

David Morse

Chief Regulatory Officer and Senior Vice President

BioVie

BioVie Pipeline

DrugIndicationPhase
Bezisterim (NE3107)Alzheimer's DiseasePhase 3
BIV201Refractory Ascites due to Liver CirrhosisPhase 2b